- Home
- FHTX vs CIA Comparison
FHTX vs CIA Comparison
Compare FHTX & CIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHTX
- CIA
- Stock Information
- Founded
- FHTX 2015
- CIA 1969
- Country
- FHTX United States
- CIA United States
- Employees
- FHTX N/A
- CIA N/A
- Industry
- FHTX Medicinal Chemicals and Botanical Products
- CIA Life Insurance
- Sector
- FHTX Health Care
- CIA Finance
- Exchange
- FHTX Nasdaq
- CIA Nasdaq
- Market Cap
- FHTX 237.4M
- CIA 230.6M
- IPO Year
- FHTX 2020
- CIA N/A
- Fundamental
- Price
- FHTX $5.23
- CIA $5.18
- Analyst Decision
- FHTX Strong Buy
- CIA
- Analyst Count
- FHTX 6
- CIA 0
- Target Price
- FHTX $13.17
- CIA N/A
- AVG Volume (30 Days)
- FHTX 163.3K
- CIA 122.6K
- Earning Date
- FHTX 03-06-2025
- CIA 03-13-2025
- Dividend Yield
- FHTX N/A
- CIA N/A
- EPS Growth
- FHTX N/A
- CIA N/A
- EPS
- FHTX N/A
- CIA 0.43
- Revenue
- FHTX $25,515,000.00
- CIA $248,376,000.00
- Revenue This Year
- FHTX N/A
- CIA N/A
- Revenue Next Year
- FHTX $8.30
- CIA $3.85
- P/E Ratio
- FHTX N/A
- CIA $11.98
- Revenue Growth
- FHTX N/A
- CIA 3.02
- 52 Week Low
- FHTX $3.86
- CIA $1.78
- 52 Week High
- FHTX $10.25
- CIA $5.95
- Technical
- Relative Strength Index (RSI)
- FHTX 52.39
- CIA 53.85
- Support Level
- FHTX $3.89
- CIA $5.17
- Resistance Level
- FHTX $6.27
- CIA $5.56
- Average True Range (ATR)
- FHTX 0.59
- CIA 0.33
- MACD
- FHTX 0.11
- CIA -0.04
- Stochastic Oscillator
- FHTX 48.38
- CIA 44.90
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
About CIA Citizens Inc. ($1.00 Par)
Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. the Company derives its revenues principally from life insurance premiums earned for insurance coverages provided to insureds in our two operating segments and net investment income. The company operates in two business segments namely the Life Insurance segment and the Home Service Insurance segment. The company majority generates revenues from Life Insurance segment.